Aurobindo Pharma gets Canada nod for terbinafine
MUMBAI, Dec 24 (Reuters) - Drug maker Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) said on Wednesday it received the Canadian regulatory approval to sell terbinafine hydrochloride tablets in multiple strengths.
The drug is the generic equivalent of Novartis' (NOVN.VX: Quote, Profile, Research) Lamisil indicated for the treatment of fungal infections in the skin and nails, the company said in a statement. (Reporting by Bharghavi Nagaraju; Editing by Prem Udayabhanu)
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
Greek crisis sets euro zone enlargement back
The Greek debt crisis has dealt a setback to prospects of enlarging the euro zone by highlighting the difficulties of managing the single currency area. Full Article
India
US
UK
